Nanoparticle-based targeted drug delivery
By Rajesh K. Singh, J. Lillard. Experimental and molecular pathology (Print), 2009
2,559 citations recorded by the source corpus.
Nanotechnology could be defined as the technology that has allowed for the control, manipulation, study, and manufacture of structures and devices in the “nanometer” size range. These nano-sized objects, e.g., “nanoparticles”, take on novel properties and functions that differ markedly from those seen from items made of identical materials. The small size, customized surface, improved solubility, and multi-functionality of nanoparticles will continue to open many doors and create new biomedical applications. Indeed, the novel properties of nanoparticles offer the ability to interact with complex cellular functions in new ways. This rapidly growing field requires cross-disciplinary research and provides opportunities to design and develop multifunctional devices that can target, diagnose, and treat devastating diseases such as cancer. This article presents an overview of nanotechnology for the biologist and discusses the attributes of our novel XPclad© nanoparticle formulation that has shown efficacy in treating solid tumors, for single dose vaccination, and oral delivery of therapeutic proteins.
Subfields: Biomaterials, Molecular Biology, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/cbefb0bcb24e65b7d7f4e059e9662044bddf3b17
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
- Huaqing Xie
- Elbay Malikmammadov
- T. E. Tanir
- V. Hasırcı
- Wei Yu
- A. Kiziltay
- S. Bhattacharjee
- N. Hasırcı
In Molecular Biology
In Pharmaceutical Science
Citations in the corpus
- PCL and PCL-based materials in biomedical applications (2018, background): “Therapeutic molecules such as drugs, proteins, and polynucleotides can be loaded into carrier systems in order to improve bioavailability, to increase aqueous solubility and stability, and therefore, control the amount and rate of delivery [34,35], where nano ones can cross biological barriers as bl”
- An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery (2017, background): “There are several mechanisms which govern drug release from chitosan nanoparticles such as: swelling of the polymer [25], diffusion of the adsorbed drug, drug diffusion through the polymeric matrix, polymer erosion or degradation and a combination of both erosion and degradation [26] as represented ”
- Metal nanoparticles: understanding the mechanisms behind antibacterial activity (2017, background): “NPs have increasingly been used in industry over the past few decades with usages varying from food additives [1] to drug administration [2].”
- Molecular Communication and Networking: Opportunities and Challenges (2012, background): “Implanted bio-nanomachines can use molecular signals within the organism, or molecular signals released by other bio-nanomachines, to pinpoint target locations for drug delivery and thereby reduce the potential for side-effects at non-target locations [31]–[33].”
- DLS and zeta potential - What they are and what they are not? (2016, background): “, macromolecules [16], peptides [17]) and release at target sites (e.”